To register for MyChart, our patient communication and information system, please choose from the following options:
If you have an activation code from your enrollment letter/provider:
Don't have a code?
How-to guides and tips for MyChart Users
Get an immediate, self-serve price estimate through MyChart - no account or login required!
INDIANAPOLIS (February 7, 2025)—A first for Indiana, Community Health Network incorporates new, innovative technology to treat atrial fibrillation (AFib), the most common type of irregular heartbeat.
Community Heart and Vascular Hospital recently became the first location in the state and the seventh in the country to use the Sphere-9™ Catheter. The Medtronic device is among the latest innovations available for treating AFib.
According to the Centers for Disease Control (CDC), more than 12 million people will have AFib by the year 2030. This heart condition can lead to an increased risk of stroke, blood clots in the heart, and heart failure. The risk for AFib increases with age. Other risk factors include high blood pressure, obesity, smoking, moderate to heavy alcohol use, diabetes, and European ancestry.
AFib is an irregular heartbeat that indicates a short circuit in the heart’s electrical system. While there is no cure for AFib, treatments and lifestyle changes can help manage the condition.
The Sphere-9™Catheter is used in procedures by electrophysiologists who focus on the wiring of the heart. The catheter can help map and pinpoint the abnormal heart tissue that could be causing the irregular heartbeat. It is then used to freeze or burn the tissue, creating scars that can stop the electrical impulses causing the problem. The procedures are called ablations. The Sphere-9™ advancements in mapping and control have proven to be safe, effective and can cut down the procedure time for patients by 25 minutes.
“The Medtronic sphere 9 catheter with the Affera mapping system has been a great advancement in mapping and ablation of complex arrhythmias and has shown great promise in advancing ablation therapies for Atrial fibrillation”, said Dr. Krishna Malineni, Electrophysiologist Medical Director at Community Heart and Vascular Hospital. “It gives us the tool to map and ablate at the same time safely while applying fewer lesions in the heart. This will make the procedures safer and suggest greater efficacy. We are excited about the initial experiences with it and look forward to treating patients who suffer from atrial fibrillation with this latest technology.”
The Sphere-9™ use is one of many "firsts" for the team at Community Heart and Vascular Hospital in their treatment of AFib. Others include being the first healthcare system in the state to use Pulsed Field Ablation, install the Aurora EV-ICD, and utilize TruSteer technology all in 2024 as part of an effort to treat this heart condition impacting millions of lives and offer a better quality of life for patients.
For more information on the many options available for reducing stroke risk, go to www.eCommunity.com.
